Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A rules-based algorithm to identify patients who would benefit from re-addressing advance care planning
    Meeting Abstract

    Bestvina, C. M.; Daly, R. M.; Wroblewski, K.; Huber, M.; Malec, M.; Chow, S. L. M.; Hantel, A.; Beach, B.; Polite, B. N.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC
    Meeting Abstract

    Arbour, K. C.; Sequist, L. V.; Piotrowska, Z.; Kris, M. G.; Paik, P. K.; Ni, A.; Plodkowski, A.; Riely, G.; Yu, H. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Long-term survival in patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab
    Meeting Abstract

    Topalian, S. L.; Hodi, F. S.; Brahmer, J. R.; Gettinger, S. N.; Smith, D. C.; McDermott, D. F.; Powderly, J. D.; Sosman, J. A.; Atkins, M. B.; Spigel, D. R.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • ENCORE-601: Phase 1b/2 study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Gandhi, L.; Johnson, M. L.; Opyrchal, M.; Ramalingam, S.; Janne, P.; Chachoua, A.; Ordentlich, P.; Brouwer, S.; Sankoh, S.; Schmidt, E.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Clinical activity of adenosine 2A receptor (A2AR) inhibitor CPI-444 is associated with tumor expression of adenosine pathway genes and tumor immune modulation
    Meeting Abstract

    Hotson, A.; Powderly, J.; Emens, L.; Forde, P.; Hellman, M.; Fong, L.; Markman, B.; Hughes, B.; Goldman, J.; Sznol, M.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • [F18]PARPi PETas an in vivo biomarker of intratumoral parp inhibition in small cell lung cancer
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Radiation Oncology (2017)

    Fulltext@MSK | Save
  • What, when, and how of biomarker testing in non-small cell lung cancer
    Journal Article

    Riely, G. L.
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save
  • A first-in-class TWIST1 inhibitor with activity in oncogene-driven lung cancer
    Journal Article

    Yochum, Z. A.; Cades, J.; Mazzacurati, L.; Neumann, N. M.; Khetarpal, S. K.; Chatterjee, S.; Wang, H.; Attar, M. A.; Huang, E. H. B.; Chatley, S. N.; more...
    Molecular Cancer Research (2017)

    Fulltext@MSK | Save
  • Case for stopping targeted therapy when lung cancer progresses on treatment in hospice-eligible patients
    Journal Article

    Smith, T. J.; Hanna, N.; Johnson, D.; Baker, S. Jr; Biermann, W. A.; Brahmer, J.; Ellis, P. M.; Giaccone, G.; Hesketh, P. J.; Jaiyesimi, I.; more...
    Journal of Oncology Practice (2017)

    Fulltext@MSK | Save